» Articles » PMID: 14561907

The Rates and CT Patterns of Locoregional Recurrence After Resection Surgery of Lung Cancer: Correlation with Histopathology and Tumor Staging

Overview
Date 2003 Oct 17
PMID 14561907
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of our study was to assess the rates and CT patterns of locoregional recurrence after resection surgery of lung cancers according to histopathology and tumor staging. Three hundred and seventy nine patients who underwent lung resection surgery due to lung cancer in a recent 6 year period were followed up with CT (at 3, 6, 12, 18, 24 months, and then annually after surgery) for evaluation of locoregional tumor recurrence (analysis of hilar or mediastinal lymph nodes and surgical margin including bronchial stump, pleura, and chest wall). The recurrence rates and CT patterns were compared in terms of underlying histopathology and tumor staging. Of 379 patients, 75 (20%) patients had locoregional recurrences. The recurrence rates were higher in squamous cell carcinoma (39/190, 21%) than adenocarcinoma (24/140, 17%) (P = 0.012). The patterns of recurrence in 75 patients were hilar-mediastinal lymph node enlargement (n = 39, 52%), ipsilateral pleural lesion (n = 24, 32%), chest wall lesion (n = 13, 17%), bronchial stump lesion (n = 8, 11%), and bronchial extension including the trachea (n = 3, 4%). Bronchial stump recurrence was seen only in squamous cell carcinoma. Bronchioloalveolar carcinoma did not show any evidence of locoregional recurrence. Pleural (P = 0.0016) and mediastinal nodal (P = 0.001) recurrence, respectively, were more common in N2 than N0 cancers. Chest wall recurrence rates were higher with higher T staging (P < 0.001). The locoregional recurrence of lung cancer occurs in about one fifth of patients who undergo curative resection and is more common in squamous cell carcinoma than in adenocarcinoma. Recurrent patterns are diverse and different according to histopathologic type and pathologic staging of lung cancer.

Citing Articles

Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma.

Parker A, Bowman E, Zingone A, Ryan B, Cooper W, Kohonen-Corish M Genome Med. 2022; 14(1):126.

PMID: 36404344 PMC: 9677915. DOI: 10.1186/s13073-022-01127-6.


Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection.

Choi P, Jeong S, Yoon S J Thorac Dis. 2016; 8(1):152-60.

PMID: 26904224 PMC: 4740133. DOI: 10.3978/j.issn.2072-1439.2016.01.10.


Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions.

Shafirstein G, Battoo A, Harris K, Baumann H, Gollnick S, Lindenmann J Ann Am Thorac Soc. 2015; 13(2):265-75.

PMID: 26646726 PMC: 5015713. DOI: 10.1513/AnnalsATS.201509-650FR.


CT Characteristic of Early Local Recurrence After Resection of the Squamous Cell Carcinoma: Comparison With CT Characteristics of Stump Deformity or Granulation Tissue at Stump Site.

Hwang H, Kim M, Kim S, Choi C Medicine (Baltimore). 2015; 94(41):e1691.

PMID: 26469905 PMC: 4616788. DOI: 10.1097/MD.0000000000001691.


Lung cancer prognosis before and after recurrence in a population-based setting.

Consonni D, Pierobon M, Gail M, Rubagotti M, Rotunno M, Goldstein A J Natl Cancer Inst. 2015; 107(6):djv059.

PMID: 25802059 PMC: 4838060. DOI: 10.1093/jnci/djv059.